ACS14
ACS14 is a derivative of Aspirin. ACS14 reduces Buthionine Sulfoximine (BSO) (HY-106376) -induced hypertension, plasma levels of thromboxane B2, 8-isoprostane, and insulin in rats, while GSH remained in the control range. ACS14 can be used for hypertension research[1].
Product Specifications
CAS Number
894430-68-3
UNSPSC
12352005
Target
Drug Derivative
Related Pathways
Others
Field of Research
Cardiovascular Disease
Purity
95.66
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C(C1=C(OC(C)=O)C=CC=C1)OC2=CC=C(C(SS3)=CC3=S)C=C2
Molecular Formula
C18H12O4S3
Molecular Weight
388.48
References & Citations
[1]Rossoni G, et al. Activity of a new hydrogen sulfide-releasing aspirin (ACS14) on pathological cardiovascular alterations induced by glutathione depletion in rats. Eur J Pharmacol. 2010 Dec 1;648 (1-3) :139-45.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
